Maintenance Notice (4:30 AM - 11:00 AM December 21, 2024): This website is scheduled to be unavailable due to maintenance. We appreciate your patience and understanding.
Published TCIMAIL newest issue No.197
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 152628-02-9 | Product Number: D5079
1,7'-Dimethyl-2'-propyl-2,5'-bibenzimidazole
×
![]()
×
Purity: >98.0%(HPLC)
Synonyms:
Product Documents:
| Size | Unit Price | Belgium | Japan* |
|---|---|---|---|
| 5G |
€63.00
|
Contact Us | 2 |
| 25G |
€238.00
|
Contact Us | 5 |
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
| Product Number | D5079 |
| Purity / Analysis Method | >98.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__1__9H__2__0N__4 = 304.40 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
| CAS RN | 152628-02-9 |
| Reaxys Registry Number | 6608725 |
| PubChem Substance ID | 468591287 |
| MDL Number | MFCD09029193 |
Specifications
| Appearance | White to Light yellow to Light orange powder to crystaline |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 95.0 % |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 130 °C(dec.) |
| Solubility (soluble in) | Methanol |
GHS
Related Laws:
Transport Information:
| HS Number | 2933998090 |
Application
A Key Synthetic Intermediate of Telmisartan
This product has been used as a key synthetic intermediate of telmisartan [T2861] which is an angiotensin II receptor type 1 (AT1) antagonist.
References
- An Efficient and Impurity-Free Process for Telmisartan: An Antihypertensive Drug
- Synthesis and biological activities of novel nonpeptide angiotensin II receptor antagonists based on benzimidazole derivatives bearing a heterocyclic ring
- Design, Synthesis, and Docking Studies of Novel Benzimidazoles for the Treatment of Metabolic Syndrome
- Stability-indicating HPLC method for simultaneous estimation of low level impurities of telmisartan and hydrochlorothiazide in tablet dosage forms
- AQbD-Oriented Development of a New LC Method for Simultaneous Determination of Telmisartan and Its Impurities
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.